KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease.
Nam MH, Park JH, Song HJ, Choi JW, Kim S, Jang BK, Yoon HH, Heo JY, Lee H, An H, Kim HJ, Park SJ, Cho DW, Yang YS, Han SC, Kim S, Oh SJ, Jeon SR, Park KD, Lee CJ.
Nam MH, et al.
Neurotherapeutics. 2021 Jul;18(3):1729-1747. doi: 10.1007/s13311-021-01097-4. Epub 2021 Oct 5.
Neurotherapeutics. 2021.
PMID: 34611843
Free PMC article.